Literature DB >> 1573505

The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children.

J B Gouyon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1573505     DOI： 10.1097/00005176-199201000-00029

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  3 in total

1.  Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.

Authors:  P C Ng; K W So; K S Fung; C H Lee; T F Fok; E Wong; W Wong; K L Cheung; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Erythromycin as a prokinetic agent in preterm neonates: a systematic review.

Authors:  S Patole; S Rao; D Doherty
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-17       Impact factor: 5.747

3.  High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.

Authors:  Pak C Ng; Cheuk H Lee; Samuel P S Wong; Hugh S Lam; Flora Y B Liu; King W So; Cheuk Y Lee; Tai F Fok
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.